ABSTRACT
The rising older population in Japan is associated with a rise in cases of dementia. Support for the increased number of family caregivers of people living with dementia is crucial, as caring may negatively affect a family caregiver's health. This study seeks to evaluate the feasibility and applicability of a recently developed Japanese version of START (STrAtegies for RelaTives). START is a psychosocial coping intervention program developed in the United Kingdom that has been shown to improve caregivers' mood and quality of life in a randomized controlled trial. We made changes to START (e.g., idioms, linguistic nuance, and providing care insurance information suited for Japan) to make it culturally appropriate. Fourteen Japanese female family caregivers of relatives with mild dementia (n = 10) or mild cognitive impairment (n = 4) were referred to the study, but six were excluded owing to illness and busyness. This single-arm study had a before-after trial evaluating psychological outcomes including depression, anxiety, quality of life, and subjective care burden. The acceptance retention and satisfaction rate suggest the feasibility and acceptability of the START program; 8/14 (>55%) eligible, prospective participants consented and were included in this study, all (8/8) of whom completed all START sessions. The mean program satisfaction score was 30.25 (standard deviation = 2.25) out of a potential 32. The results suggest that it is feasible and acceptable to deliver START in Japanese and based on the results of analysis using a linear mixed model, there is initial indication that the intervention improved family caregivers' quality of life, depressive symptoms, and care burden.
Subject(s)
Adaptation, Psychological , Caregivers , Dementia , Caregivers/psychology , Dementia/nursing , Feasibility Studies , Female , Humans , Japan , Prospective Studies , Quality of Life , United KingdomABSTRACT
A previous study reported that a massive cerebral infarct in the territory of the middle cerebral artery (MCA) may be associated with development of neurofibrillary tangles (NFTs) in the ipsilateral basal nucleus of Meynert (BNM). We analyzed 19 cases of an MCA territory infarct and 12 with a putaminal hemorrhage (mean age 82.5 years; female/male ratio 8/23; mean time from stroke onset to autopsy 4182 days). In both groups, 74-100% had a significantly higher rate of phosphorylated tau immunoreactive or Gallyas Braak silver stain-positive neurons on the BNM-affected side than on the BNM-unaffected side. These NFTs were immunoreactive for anti-RD3 and anti-RD4 antibodies, and a triple-band pattern was observed by immunoblot analysis with anti-tau antibody. Most NFTs might be formed within the 5-10 years after stroke onset. There were significantly more TAR DNA-binding protein 43 (TDP43) immunoreactive structures on the BNM-affected side than on the BNM-unaffected side. We showed that many NFTs with TDP43-immunoreactive structures were observed in the ipsilateral BNM associated with a massive cerebral infarct in the MCA territory or a putaminal hemorrhage.
Subject(s)
Basal Nucleus of Meynert/metabolism , Cerebral Hemorrhage/metabolism , Cerebral Infarction/metabolism , DNA-Binding Proteins/metabolism , Neurofibrillary Tangles/metabolism , tau Proteins/metabolism , Aged , Aged, 80 and over , Basal Nucleus of Meynert/chemistry , Basal Nucleus of Meynert/pathology , Cerebral Hemorrhage/pathology , Cerebral Infarction/pathology , DNA-Binding Proteins/analysis , Female , Humans , Male , Neurofibrillary Tangles/chemistry , Neurofibrillary Tangles/pathology , tau Proteins/analysisABSTRACT
A 59-year-old woman was admitted to our hospital because of repeated episodes of bilateral hand weakness. She had a 10-year history of combined estrogen-progestin therapy for menopausal symptoms. Magnetic resonance imaging on admission showed multiple hyperintense lesions in bilateral cerebral and cerebellar cortices on diffusion-weighted imaging. Transesophageal echocardiography showed thrombus formation on the aortic valve and moderate aortic insufficiency. Laboratory test demonstrated elevated CA125 (334.8 U/mL) and D-dimer (7.0 µg/mL) levels. Trousseau's syndrome (cancer-related hypercoagulation) was considered, but various examinations showed only uterine adenomyosis and no evidence of cancer. Multiple cerebral infarctions were considered to be caused by Trousseau's syndrome-like condition associated with uterine adenomyosis. CA125 and coagulation markers should be measured in adenomyosis patients treated with hormone replacement therapy, because a mucinous tumor and coagulation markers may be good markers for the risk of thromboembolism in such patients.
Subject(s)
Adenomyosis/complications , Blood Coagulation , Cerebral Infarction/etiology , Estrogen Replacement Therapy , Hand/innervation , Thrombophilia/etiology , Adenomyosis/blood , Adenomyosis/diagnosis , Biomarkers/blood , Blood Coagulation/drug effects , CA-125 Antigen/blood , Cerebral Infarction/blood , Cerebral Infarction/diagnostic imaging , Cerebral Infarction/physiopathology , Diffusion Magnetic Resonance Imaging , Echocardiography, Transesophageal , Estrogen Replacement Therapy/adverse effects , Female , Fibrin Fibrinogen Degradation Products/analysis , Humans , Membrane Proteins/blood , Middle Aged , Muscle Weakness , Thrombophilia/blood , Thrombophilia/diagnosisSubject(s)
Anticoagulants/administration & dosage , Anticoagulants/adverse effects , Cerebral Hemorrhage/drug therapy , Pyridines/administration & dosage , Pyridines/adverse effects , Thiazoles/administration & dosage , Thiazoles/adverse effects , Administration, Oral , Aged, 80 and over , Brain/diagnostic imaging , Brain/drug effects , Cerebral Hemorrhage/diagnostic imaging , Cerebral Hemorrhage/physiopathology , Drug Therapy, Combination/adverse effects , Female , Humans , Recurrence , Stroke/diagnostic imaging , Stroke/drug therapy , Stroke/physiopathology , Thrombolytic Therapy/adverse effectsABSTRACT
Spontaneous cervical artery dissection (sCAD) is a major cause of ischemic stroke in young adults. Frequently, sCAD involves multiple neck arteries, accounting for 13%-28% of the total sCAD cases. However, little is known about factors related to multiple sCAD. In this case, a 52-year-old man was admitted due to headache without aura. There was a personal history of migraine with aura and a family history of similar symptoms. The patient's younger brother had a left vertebral artery (VA) dissecting aneurysm and underwent endovascular occlusion of his parent artery at the age of 48. Magnetic resonance imaging of our admitted patient showed hyperintensities in the right internal carotid artery (ICA) without acute infarction, and magnetic resonance angiography revealed a narrowing of the right ICA. Angiography was then performed, which showed a trace of dissection of the left ICA and both VAs as well as the right ICA. The patient did not fulfill any major criteria of collagen vascular disease such as Ehlers-Danlos syndrome type IV or Loeys-Dietz syndrome. The data in our patient are quite similar to those reported in patients with single-nucleotide polymorphism (SNP) of PHACTR1. Obtaining the patient's informed consent, we analyzed a common SNP variation in the rs9349379[G] allele (PHACTR1), which has been reported to be associated with a lower risk of sCAD.
Subject(s)
Carotid Artery, Internal, Dissection/genetics , Collagen/genetics , Polymorphism, Single Nucleotide/genetics , Vertebral Artery Dissection/genetics , Asian People , Carotid Artery, Internal, Dissection/complications , Carotid Artery, Internal, Dissection/diagnostic imaging , Humans , Imaging, Three-Dimensional , Magnetic Resonance Angiography , Magnetic Resonance Imaging , Male , Middle Aged , Vertebral Artery Dissection/complications , Vertebral Artery Dissection/diagnostic imagingSubject(s)
Aspirin/therapeutic use , Platelet Aggregation Inhibitors/therapeutic use , Thrombocythemia, Essential/drug therapy , Thrombocythemia, Essential/physiopathology , Ticlopidine/analogs & derivatives , Clopidogrel , Drug Resistance , Humans , Male , Middle Aged , Ticlopidine/therapeutic use , Vasomotor System/drug effects , Vasomotor System/physiopathologyABSTRACT
BACKGROUND AND OBJECTIVE: Loss of intermediolateral nucleus (IML) neurons is considered to play a major role in orthostatic hypotension (OH) of multiple system atrophy (MSA). In Parkinson disease (PD) and dementia with Lewy bodies (DLB), autonomic phenomena such as OH are common and attributed to dysfunction of sympathetic, parasympathetic, and visceral autonomic neurons. However, apart from MSA, few reports have focused on the neuropathologic aspects in PD and DLB. Here we assessed IML degeneration as well as the fine myelinated fibers (FFs; maximum diameter less than 3 µm) considered to be preganglionic sympathetic nerve fibers derived from IML neurons in PD, DLB, MSA, and age-matched normal controls (NC). METHODS: We counted IML neurons and measured the diameter and number of myelinated fibers of the ventral root at the level of the 12th thoracic segment. RESULTS: Compared to NC, number of IML neurons and density of FF were significantly reduced in PD (53% and 67%), DLB (47% and 71%) and MSA (27% and 42%). Compared to combined group of PD and DLB without OH (OH-), IML neurons in combined group of PD and DLB with OH (OH+) were significantly reduced (77%). Compared to NC, FF densities in OH-, OH+ were significantly reduced (74% and 59%). The mean ratio of small to large myelinated fibers in OH+ (1.18), but not that in OH-(1.58), was significantly lower than that in NC (3.17). CONCLUSIONS: We present neuropathological evidence that IML neurons and FFs in the ventral root are reduced in PD and DLB and that the reduction was more severe in the combined group of OH+ than in OH-.
Subject(s)
Lewy Body Disease/pathology , Neurons/pathology , Parkinson Disease/pathology , Spinal Cord Lateral Horn/pathology , Spinal Nerve Roots/pathology , Aged , Aged, 80 and over , Female , Humans , Hypotension, Orthostatic/complications , Hypotension, Orthostatic/pathology , Lewy Body Disease/complications , Male , Nerve Fibers/pathology , Parkinson Disease/complicationsABSTRACT
A 59-year old man was admitted to our stroke care unit 1.8 hours after onset of cardioembolic stroke. Administration of issue-plasminogen activator achieved complete recanalization, and his lesion on diffusion-weighted imaging (DWI) disappeared and single photon emission computed tomography showed luxury perfusion. DWI reversal and luxury perfusion were sometimes observed in hyperacute stroke patients, especially timely reperfusion was achieved. However, the relationships between DWI reversal and luxury perfusion were not well known. Transient DWI reversal may be associated with luxury perfusion in patients treated with t-PA, via early complete recanalization achieved by thrombolysis.
Subject(s)
Brain Edema/etiology , Cerebral Revascularization , Fibrinolytic Agents/therapeutic use , Infarction, Middle Cerebral Artery/drug therapy , Reperfusion Injury/etiology , Thrombolytic Therapy , Tissue Plasminogen Activator/therapeutic use , Diffusion Magnetic Resonance Imaging , Fibrinolytic Agents/adverse effects , Humans , Infarction, Middle Cerebral Artery/diagnostic imaging , Infarction, Middle Cerebral Artery/pathology , Infarction, Middle Cerebral Artery/physiopathology , Magnetic Resonance Angiography , Male , Middle Aged , Multimodal Imaging , Neuroimaging , Putamen/blood supply , Temporal Lobe/blood supply , Thrombolytic Therapy/adverse effects , Tissue Plasminogen Activator/adverse effects , Tomography, Emission-Computed, Single-PhotonABSTRACT
BACKGROUND: Lewy body-related α-synucleinopathy (LBAS, the abnormal accumulation of pathologic α-synuclein) is found in the central and peripheral nervous systems, including the spinal cord, dorsal root ganglia, and sympathetic ganglia, of Parkinson's disease patients. However, few studies have focused on the distribution of LBAS in the spinal cord, primary sensory neurons, and preganglionic sympathetic nerves. RESULTS: We analyzed 265 consecutive subjects with LBAS who underwent autopsy at a general geriatric hospital. LBAS in the spinal cord was significantly associated with that in the lower brainstem regions that are directly connected to the spinal cord (i.e., the medullary reticular formation and locus ceruleus), but it was not associated with the olfactory bulb-amygdala system, which is not directly connected to the spinal cord, suggesting that the lower brainstem is a key structure regarding the spread of LBAS to the spinal cord. In the primary sensory neurons, most subjects with LBAS in the dorsal root ganglia had LBAS in the dorsal root, and all subjects with LBAS in the dorsal root also had LBAS in the dorsal horn, suggesting that LBAS spreads retrogradely from the axonal terminals of the dorsal horn to the somata of the dorsal root ganglia via the dorsal root. In the preganglionic sympathetic nerves, the LBAS in the sympathetic ganglia preceded that in the nucleus of the intermediolateral column of the thoracic cord, suggesting that LBAS spreads retrogradely through the preganglionic sympathetic nerves. CONCLUSIONS: LBAS in the spinal cord was associated with the lower regions of the brainstem, but not with the olfactory bulb or amygdala. LBAS may spread centrifugally along the primary sensory neurons, whereas it may spread centripetally along the preganglionic sympathetic nerves.
Subject(s)
Aging/pathology , Ganglia, Spinal/metabolism , Neurons/metabolism , Spinal Cord/metabolism , alpha-Synuclein/metabolism , Aged , Aged, 80 and over , Autopsy , Brain/metabolism , Brain/pathology , Chi-Square Distribution , Cohort Studies , Female , Ganglia, Spinal/pathology , Humans , Lewy Body Disease/pathology , Male , Psychiatric Status Rating Scales , Spinal Cord/pathology , Statistics, NonparametricABSTRACT
INTRODUCTION: The transactivation response element DNA-binding protein 43 kDa (TDP-43) is a major component of the ubiquitin-positive and tau-negative inclusions in frontotemporal lobar degeneration and sporadic amyotrophic lateral sclerosis (ALS). TDP-43 may accumulate in cases of Alzheimer's disease (AD), Lewy body disease (LBD), and argyrophilic grain disease (AGD). However, few studies have focused on the incidence and extent of TDP-43 deposition in aging. RESULTS: We analyzed 286 consecutive autopsy brains neuropathologically. Of these, 136 brains with pathologically minimal senile changes were designated as control elderly brains (78.5 ± 9.7 y). For comparison, we selected 29 AD, 11 LBD, and 11 AGD patients from this series of autopsy brains. Sections of the hippocampus, amygdala, medulla oblongata, and lumbar spinal cord were immunostained with anti-phosphorylated TDP-43 antibody (PSer409/410). TDP-43 immunoreactive structures were classified into four types: dystrophic neurites (DNs), neuronal or glial cytoplasmic inclusions, and intranuclear inclusions. TDP-43 immunoreactive structures were observed in 55/136 control elderly (40.0%), 21/29 AD (72.4%), 8/11 LBD (72.7%), and 6/11 AGD (54.5%) brains. TDP-43 immunoreactive structures in control elderly brains were mostly DNs. These DNs were predominantly present in the uncus of the anterior hippocampus over age 65. The frequency of cases with DNs in the amygdala of control elderly brains was less than that of AD, LBD, and AGD brains. The mean age at death was significantly higher in cases with TDP-43 immunoreactive structures than cases without them. CONCLUSIONS: In conclusion, TDP-43 immunoreactive DNs may develop as a consequence of aging processes in the human brain. In particular, the uncus of the anterior hippocampus is an area highly susceptible to TDP-43 accumulation over age 65.
Subject(s)
Aging/pathology , Brain/metabolism , DNA-Binding Proteins/metabolism , Dementia , Adult , Aged , Aged, 80 and over , Autopsy , Community Health Services , Dementia/epidemiology , Dementia/metabolism , Dementia/pathology , Female , Humans , Incidence , Male , Middle Aged , Neurofibrillary Tangles/metabolism , Neurofibrillary Tangles/pathology , Retrospective Studies , Spinal Cord/metabolismABSTRACT
Diagnosing clinical progressive supranuclear palsy (PSP) is challenging. We hypothesize that there are more cases of pathological PSP than have been clinically identified, but its diagnosis is challenging because the initial lesions and progression of PSP have not yet been clarified. The purpose of our study was to clarify the incidence of PSP in consecutive autopsy cases and identify pathological characteristics of early PSP. We investigated 324 consecutive autopsy patients from a general geriatric hospital (age, mean±SD=82.5±8.7 years). Paraffin sections of the midbrain were immunostained with anti 4-repeat tau antibodies (RD4). We selected cases showing RD4-positive neurofibrillary tangles and tufted astrocytes in the midbrain sections. Then, we used anti-phosphorylated tau antibody to immunostain sections from the basal ganglia, subthalamic nucleus, midbrain, pons, medulla, and cerebellum. Of the 324 patients, 35 had RD4-positive structures in the midbrain. From these 35 cases, we excluded those for which autopsies confirmed definite PSP (n=5) and cases of corticobasal degeneration (n=1), Alzheimer's disease (n=11), dementia of grain (n=10), and neurofibrillary tangles predominant forms of senile dementia (n=2), leaving 8 cases. We diagnosed these 8 cases as pure PSP-type tauopathy. Pure PSP-type tauopathy was detected in 2.5% of the consecutive autopsy cases, and this incidence was 1.6 times greater than that of neuropathologically definite PSP. This pure PSP-type tauopathy likely indicates preclinical stages of PSP. Furthermore, the novel neuropathological finding, which we term "preclinical PSP," is unique and has not previously been reported. In order to elucidate the causes and pathological mechanisms of PSP, preclinical PSP should be investigated further.